PMI-31

N/A

Report date: 2024/05/14 17:36:29

Base Information

Drug NamePMI-31
Drug Alias NamePMI-31
ClassificationRadiation-emitting products
Mechanisms of ActionIonising radiation emittersFibroblast activation protein alpha modulators
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrecision Molecular Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrecision Molecular Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A